AURIGENE ONCOLOGY LIMITED
Location
Karnataka
Founded
2001-08-10
Website
Risk Signals
17 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about AURIGENE ONCOLOGY LIMITED
Live alerts from global media, monitored by Business Radar
(cnbctv18.com)
Dr Reddy's unit achieves trial breakthrough: Positive results for blood cancer treatment - CNBC TV18
"The results from the trial in heavily pre-treated relapsed refractory myeloma patients are very exciting for us in India," said Murali Ramachandra, CEO of Aurigene Oncology. "We are thrilled with the data, as the drug could be transformative for Indian patients with myeloma."
Read more